Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Unresectable Advanced Gastric Carcinoma and Recurrent Gastric Carcinoma

NCT00503321 is registered in ClinicalTrials.gov with Eastern Network of Cancer Immunological Therapy, Japan as lead sponsor.

NCT NCT00503321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00503321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Unresectable Advanced Gastric Carcinoma and Recurrent Gastric Carcinoma
Lead sponsor
Eastern Network of Cancer Immunological Therapy, Japan
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2006
Completion date
August 31, 2011
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer